Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study

J Infect. 2022 Nov;85(5):e140-e144. doi: 10.1016/j.jinf.2022.08.008. Epub 2022 Aug 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Cardiovascular Diseases* / prevention & control
  • Case-Control Studies
  • Diabetes Mellitus*
  • Hospitalization
  • Humans
  • SARS-CoV-2
  • Vaccine Efficacy

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • BNT162 Vaccine